David Price
David Price has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Marsha A. Raebel
Institute for Health Research, Kaiser Permanente Colorado, Denver, CO, USA; University of Colorado Skaggs, School of Pharmacy and Pharmaceutical Sciences, Aurora, CO, USA
2 shared publications - Desa Patricia1 shared publication
Douglas A Conner
1 shared publication- Douglas Conner
Institute for Health Research in Denver, CO, USA
1 shared publication Kate G. Felix
1 shared publication- Kristin Wallace
Project Manager in the Department of Population and Prevention Services at Kaiser Permanente Colorado in Denver.
1 shared publication
Latest Publications
- Open Access
- 8 July 2012
- Published by Springer Nature in BMC Medical Informatics and Decision Making
- Vol. 12 (1) , 65
Comparing virtual consults to traditional consults using an electronic health record: an observational case–control study
Patients have typically received health care through face-to-face encounters. However, expansion of electronic communication and electronic health records (EHRs) provide alternative means for patient and physicians to interact. Electronic consultations may complement regular healthcare by providing “better, faster, cheaper” processes for diagnosing, treating, and monitoring health conditions. Virtual consultation between physicians may provide a method of streamlining care, potentially saving patients the time and expense of added visits. The purpose of this study was to compare physician usage and patient satisfaction with virtual consultations (VCs) with traditional consultations (TCs) facilitated within an EHR. We conducted an observational case–control survey study within Kaiser Permanente, Colorado. A sample of patients who had VCs requested by physicians (N = 270) were matched with patients who had TCs requested by physicians (N = 270), by patient age, gender, reason for the consult, and specialty department. These patients (VC and TC), were invited to participate in a satisfaction survey. In addition, 205 primary care physicians who submitted a VC or TC were surveyed. During the study period, 58,146 VC or TC were requested (TC = 96.3%). Patients who completed a satisfaction survey (267 out of 540 patients, 49.4% response rate) indicated they were satisfied with their care, irrespective of the kind of consult (mean 10-point Likert score of 8.5). 88 of 205 primary care physicians surveyed (42.9%) returned at least one survey; VC and TC survey response rates and consulted departments were comparable (p = 0.13). More TCs than VCs requested transfer of patient care (p = 0.03), assistance with diagnosis (p = 0.04) or initiating treatment (p =0.04). Within 3 weeks of the consultation request, 72.1% of respondents reported receiving information from VCs, compared with 33.9% of the TCs (p < 0.001). Utility of information provided by consultants and satisfaction with consultations did not differ between VCs and TCs. Referring physicians received information from consultants more quickly from VCs compared with TCs, but the value and application of information from both types of consultations were similar. VCs may decrease the need for face-to-face specialty encounters without a decrease in the patient’s perception of care.
- 8 July 2012
- Published by Springer Nature in BMC Medical Informatics and Decision Making
- Vol. 12 (1) , 65
Open AccessComparing virtual consults to traditional consults using an electronic health record: an observational case–control study
Patients have typically received health care through face-to-face encounters. However, expansion of electronic communication and electronic health records (EHRs) provide alternative means for patient and physicians to interact. Electronic consultations may complement regular healthcare by providing “better, faster, cheaper” processes for diagnosing, treating, and monitoring health conditions. Virtual consultation between physicians may provide a method of streamlining care, potentially saving patients the time and expense of added visits. The purpose of this study was to compare physician usage and patient satisfaction with virtual consultations (VCs) with traditional consultations (TCs) facilitated within an EHR. We conducted an observational case–control survey study within Kaiser Permanente, Colorado. A sample of patients who had VCs requested by physicians (N = 270) were matched with patients who had TCs requested by physicians (N = 270), by patient age, gender, reason for the consult, and specialty department. These patients (VC and TC), were invited to participate in a satisfaction survey. In addition, 205 primary care physicians who submitted a VC or TC were surveyed. During the study period, 58,146 VC or TC were requested (TC = 96.3%). Patients who completed a satisfaction survey (267 out of 540 patients, 49.4% response rate) indicated they were satisfied with their care, irrespective of the kind of consult (mean 10-point Likert score of 8.5). 88 of 205 primary care physicians surveyed (42.9%) returned at least one survey; VC and TC survey response rates and consulted departments were comparable (p = 0.13). More TCs than VCs requested transfer of patient care (p = 0.03), assistance with diagnosis (p = 0.04) or initiating treatment (p =0.04). Within 3 weeks of the consultation request, 72.1% of respondents reported receiving information from VCs, compared with 33.9% of the TCs (p < 0.001). Utility of information provided by consultants and satisfaction with consultations did not differ between VCs and TCs. Referring physicians received information from consultants more quickly from VCs compared with TCs, but the value and application of information from both types of consultations were similar. VCs may decrease the need for face-to-face specialty encounters without a decrease in the patient’s perception of care.
- 1 December 2009
- Vol. 15 (12) , e109-14
Pharmaceuticals from development to practice: learnings from an online curriculum.
To report outcomes of a pilot online curriculum educating clinicians about off-label prescribing, finding unbiased sources of pharmaceutical information, and responding to patient inquiries about direct-to-consumer advertised medications. Case study. We developed 3 case-oriented Internet modules to educate healthcare professionals about off-label prescribing, accessing and appraising unbiased drug information, and talking with patients about direct-to-consumer advertising. Modules included reflective questions and opportunities to asynchronously ask questions of faculty. Pilot testing occurred among 52 Kaiser Permanente Colorado prescribing clinicians from May 2007 through September 2007. We assessed self-reported changes in knowledge, intent-to-change practice, and barriers to practice change. We also examined curriculum participant pre-post changes in prescribing of selected highly advertised medications. Most participants reported changes in knowledge after curriculum completion, many made intent-to-change practice statements at curriculum completion, and several reported changes in practice 3 to 6 months after curriculum completion. Six categories of barriers to practice change were noted. Prescribing of targeted medications rose by 0.8 prescription per month in the intervention group and by 6.3 prescriptions per month in the control group, but this difference was not significant (P = .17). Targeted curricula on aspects of the pharmaceutical development, approval, and marketing process can lead to subjective changes in clinician knowledge and can facilitate intent-to-change practice. Larger studies are needed to assess the effect of such interventions on prescribing patterns.
- 1 December 2009
- Vol. 15 (12) , e109-14
Pharmaceuticals from development to practice: learnings from an online curriculum.
To report outcomes of a pilot online curriculum educating clinicians about off-label prescribing, finding unbiased sources of pharmaceutical information, and responding to patient inquiries about direct-to-consumer advertised medications. Case study. We developed 3 case-oriented Internet modules to educate healthcare professionals about off-label prescribing, accessing and appraising unbiased drug information, and talking with patients about direct-to-consumer advertising. Modules included reflective questions and opportunities to asynchronously ask questions of faculty. Pilot testing occurred among 52 Kaiser Permanente Colorado prescribing clinicians from May 2007 through September 2007. We assessed self-reported changes in knowledge, intent-to-change practice, and barriers to practice change. We also examined curriculum participant pre-post changes in prescribing of selected highly advertised medications. Most participants reported changes in knowledge after curriculum completion, many made intent-to-change practice statements at curriculum completion, and several reported changes in practice 3 to 6 months after curriculum completion. Six categories of barriers to practice change were noted. Prescribing of targeted medications rose by 0.8 prescription per month in the intervention group and by 6.3 prescriptions per month in the control group, but this difference was not significant (P = .17). Targeted curricula on aspects of the pharmaceutical development, approval, and marketing process can lead to subjective changes in clinician knowledge and can facilitate intent-to-change practice. Larger studies are needed to assess the effect of such interventions on prescribing patterns.
- 1 June 2008
- Published by The Permanente Federation in The Permanente Journal
- Vol. 12 (2) , 28-35
Prescribers' and Organizational Leaders' Preferences for Education about Heavily Marketed Drugs
We conducted a study to assess the educational needs and interests of medication prescribers and organizational needs regarding heavily marketed drugs. We used an Internet and paper-based educational needs assessment survey to gather data. Approximately 1000 Denver-area Kaiser Permanente Colorado (KPCO) physicians, nurse practitioners, and physician assistants ("health maintenance organization [HMO] prescribers"); 780 Colorado Springs KPCO network (preferred provider organization [PPO] prescribers); and 36 Denver-area KPCO pharmacy leaders were surveyed. Prescribers were asked about interest in pharmaceutical development, approval, and marketing processes and interest in learning about accessing and using drug information in practice. They were also asked to identify areas in which they would like to improve prescribing practices. Organizational leaders were asked about areas in which curricula could assist current cost-effective prescribing efforts. HMO prescriber and leader surveys were conducted via the Internet. PPO learner surveys were conducted by mail. Responses were collected from 127 (13%) HMO and 70 (9%) PPO prescribers. Top interest areas in both groups were accessing unbiased drug information, comparing evidence about drugs within class, critical appraisal of drug information, off-label drug use, and addressing patient medication inquiries. Pharmaceutical industry marketing practices, roles and responsibilities of the US Food and Drug Administration, and the US drug development and approval process were rated lowest. HMO prescribers most wanted to improve prescribing for bacterial infections, depression, and diabetes; PPO prescribers also wanted to improve prescribing for migraine headaches. Highest organizational priority drug classes were those for depression and asthma. Prescribers are interested in areas of pharmaceutical development and marketing that relate closely to providing patient care, especially in commonly seen clinical conditions. They are less interested in regulatory or policy aspects of the process.
- 1 June 2008
- Published by The Permanente Federation in The Permanente Journal
- Vol. 12 (2) , 28-35
Prescribers' and Organizational Leaders' Preferences for Education about Heavily Marketed Drugs
We conducted a study to assess the educational needs and interests of medication prescribers and organizational needs regarding heavily marketed drugs. We used an Internet and paper-based educational needs assessment survey to gather data. Approximately 1000 Denver-area Kaiser Permanente Colorado (KPCO) physicians, nurse practitioners, and physician assistants ("health maintenance organization [HMO] prescribers"); 780 Colorado Springs KPCO network (preferred provider organization [PPO] prescribers); and 36 Denver-area KPCO pharmacy leaders were surveyed. Prescribers were asked about interest in pharmaceutical development, approval, and marketing processes and interest in learning about accessing and using drug information in practice. They were also asked to identify areas in which they would like to improve prescribing practices. Organizational leaders were asked about areas in which curricula could assist current cost-effective prescribing efforts. HMO prescriber and leader surveys were conducted via the Internet. PPO learner surveys were conducted by mail. Responses were collected from 127 (13%) HMO and 70 (9%) PPO prescribers. Top interest areas in both groups were accessing unbiased drug information, comparing evidence about drugs within class, critical appraisal of drug information, off-label drug use, and addressing patient medication inquiries. Pharmaceutical industry marketing practices, roles and responsibilities of the US Food and Drug Administration, and the US drug development and approval process were rated lowest. HMO prescribers most wanted to improve prescribing for bacterial infections, depression, and diabetes; PPO prescribers also wanted to improve prescribing for migraine headaches. Highest organizational priority drug classes were those for depression and asthma. Prescribers are interested in areas of pharmaceutical development and marketing that relate closely to providing patient care, especially in commonly seen clinical conditions. They are less interested in regulatory or policy aspects of the process.
- 1 January 2008
- Published by Wolters Kluwer Health in Journal of Continuing Education in the Health Professions
- Vol. 28 (3) , 123-130
Journal clubs and case conferences: From academic tradition to communities of practice
Unknown. Methods: We used concepts of communities of practice (COPs) to structure JCs and CCs. We conducted an observational descriptive study of the learnings, implemented learnings, and barriers to implementing learnings identified in JC and CC sessions conducted in 2005–2006. Results: Two hundred learnings in 10 different categories emerged from 73 JC or CC sessions. By self-report, over half of identified learnings were implemented in practice; 60 barriers to implementing learnings (8 different categories) were also identified. Patterns of learnings, implemented learnings, and barriers varied among sessions. Discussion: JCs and CCs can be structured with explicit intent to articulate learnings and facilitate implementation of learnings in practice. Further work is needed to validate the learning and barrier categories we identified, objectively verify short- and longer-term practice outcomes, explore the role of JCs and CCs in addressing barriers to learning, and facilitate sustainability of learning in practice. Email: David.Price@kp.org or David.Price@uchsc.edu 10065 E. Harvard Avenue, Suite 300, Denver, CO 80231 Copyright © 2015 Wiley Periodicals, Inc., A Wiley Company...
- 1 January 2008
- Published by Wolters Kluwer Health in Journal of Continuing Education in the Health Professions
- Vol. 28 (3) , 123-130
Journal clubs and case conferences: From academic tradition to communities of practice
Unknown. Methods: We used concepts of communities of practice (COPs) to structure JCs and CCs. We conducted an observational descriptive study of the learnings, implemented learnings, and barriers to implementing learnings identified in JC and CC sessions conducted in 2005–2006. Results: Two hundred learnings in 10 different categories emerged from 73 JC or CC sessions. By self-report, over half of identified learnings were implemented in practice; 60 barriers to implementing learnings (8 different categories) were also identified. Patterns of learnings, implemented learnings, and barriers varied among sessions. Discussion: JCs and CCs can be structured with explicit intent to articulate learnings and facilitate implementation of learnings in practice. Further work is needed to validate the learning and barrier categories we identified, objectively verify short- and longer-term practice outcomes, explore the role of JCs and CCs in addressing barriers to learning, and facilitate sustainability of learning in practice. Email: David.Price@kp.org or David.Price@uchsc.edu 10065 E. Harvard Avenue, Suite 300, Denver, CO 80231 Copyright © 2015 Wiley Periodicals, Inc., A Wiley Company...
- 1 September 2007
- Published by The Permanente Federation in The Permanente Journal
- Vol. 11 (3) , 35-42
Diagnosis and Treatment of Major Depression 2007
Clinical Evidence Review: Best Practice By Patricia deSa, MS; David W Price, MD, FAAFP Introduction Depressive syndromes are commonly seen in the primary care setting. The National Institute of Mental Health estimates that 9.5% of adult Americans (ab
- 1 September 2007
- Published by The Permanente Federation in The Permanente Journal
- Vol. 11 (3) , 35-42
Diagnosis and Treatment of Major Depression 2007
Clinical Evidence Review: Best Practice By Patricia deSa, MS; David W Price, MD, FAAFP Introduction Depressive syndromes are commonly seen in the primary care setting. The National Institute of Mental Health estimates that 9.5% of adult Americans (ab
- 28 February 2006
- Published by Elsevier in General Hospital Psychiatry
- Vol. 28 (2) , 92-93
Translating effective depression care into practice: making an impact with IMPACT
- 28 February 2006
- Published by Elsevier in General Hospital Psychiatry
- Vol. 28 (2) , 92-93
Translating effective depression care into practice: making an impact with IMPACT
Effect of NSAIDs on risk of Alzheimer's disease
# Conclusions on NSAIDs and Alzheimer's disease were overstated {#article-title-2} EDITOR–Etminan et al present a systematic review and meta-analysis on the use of nonsteroidal anti-inflammatory drugs (NSAIDs) and the risk of developing subsequent Alzheimer's disease.1 The trials included in the review were observational studies (six cohort and three case-control). While theoretical …
Effect of NSAIDs on risk of Alzheimer's disease
# Conclusions on NSAIDs and Alzheimer's disease were overstated {#article-title-2} EDITOR–Etminan et al present a systematic review and meta-analysis on the use of nonsteroidal anti-inflammatory drugs (NSAIDs) and the risk of developing subsequent Alzheimer's disease.1 The trials included in the review were observational studies (six cohort and three case-control). While theoretical …
- 1 January 2002
- Vol. 6 (1) , 34-42
Evidence-Based Clinical Vignettes from the Care Management Institute: Major Depression.
- 1 January 2002
- Vol. 6 (1) , 34-42
Evidence-Based Clinical Vignettes from the Care Management Institute: Major Depression.